Stay updated on Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial page.

Latest updates to the Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial page
- CheckyesterdayChange DetectedThe record for the bemcentinib phase II study in patients with myelodysplastic syndromes is available, including its eligibility criteria, treatment plan, outcomes, and study locations.SummaryDifference47%

- Check8 days agoChange DetectedThe clinical trial record for bemcentinib in patients with myelodysplastic syndromes is displayed, including its study design, eligibility criteria, participating locations, and outcome measures.SummaryDifference48%

- Check15 days agoChange DetectedA banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.SummaryDifference1%

- Check22 days agoChange DetectedThe ClinicalTrials.gov error page’s footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check29 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now renders a 403 Forbidden error with a minimal HTML structure and a Home link, replacing the previous detailed study-record content. This indicates restricted access to the page.SummaryDifference18%

Stay in the know with updates to Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial page.